ArticleJACC. CardioOncology2025

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.

Anthony F Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.